Cholecystokinin-8 protects central cholinergic neurons against fimbria-fornix lesion through the up-regulation of nerve growth factor synthesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 11, 1999, Pages 6473-6477

  Tirassa, Paola ^a,b   Aloe, Luigi ^a   Stenfors, Carina ^b   Turrini, Paolo ^a   Lundeberg, Thomas ^b  

^a CNR   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Central nervous system; Choline acetyltransferase; Fimbria lesion; mRNA; Neurodegeneration

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CHOLINE ACETYLTRANSFERASE; MESSENGER RNA; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; FIMBRIA; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; MICE; NERVE GROWTH FACTORS; NEURONS; NEUROPROTECTIVE AGENTS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; SINCALIDE; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0032991818     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.11.6473     Document Type: Article

References (39)

1. Ebendal, T. (1992) J. Neurosci. Res. 32, 461-470.
2. Levi-Montalcini, R. (1987) Science 237, 1154-1162.
3. Thoenen, H., Bandtlow, C. & Heuman, R. (1987) Rev. Physiol. Biochem. Pharmacol. 109, 145-178.
4. Barker, P. A. & Murphy, R. A. (1992) Mol. Cell. Biol. 110, 1-15.
5. Shelton, D. L. & Reichardt, L. F. (1986) Proc. Natl. Acad. Sci. USA 83, 2714-2718.
6. Eide, F. F., Lowenstein, D. H. & Reichardt, L. F. (1993) Exp. Neurol. 121, 200-214.
7. Alleva E., Aloe, L. & Bigi, S. (1993) Rev. Neurosci. 4, 41-62.
8. Connor, B. & Dragunow, M. (1998) Brain Res. Rev. 27, 1-39.
9. Perry, E. K., Tomlison, B. E., Blessed, G., Bergmann, K., Gibson, P. H. & Perry, R. H. (1978) Br. Med. J. 2, 1457-1459.
10. Scott, S. A. & Crutcher, K. A. (1994) Rev. Neurosci. 5, 179-211.
11. Fricker, J. (1997) Lancet 349, 480.
12. Hefti, F. & Shneider, L. S. (1989) Psychiatr. Dev. 4, 297-315.
13. Olson, L., Nordberg, A., Von Holst, H., Backman, L., Ebendal, T., Alafuzoff, I., Amberla, K., Hartvig, P., Herlitz, A., Lilja, A., et al. (1992) J. Neural. Transm. 4, 79-95.
14. Knusel, B. & Gao, H. (1996) Life Sci. 58, 2019-2027.
15. Martinez-Serrano, A., Lundberg, C., Horellou, P., Fischer, W., Bentlage, C., Campbell, K., McKay, R. D., Mallet, J. & Bjorklund, A. (1995) J. Neurosci. 15, 5668-5680.
16. Dockray, G. J. (1976) Nature (London) 264, 568-570.
17. Beinfeld, M. C., Meyer, D. K., Eskay, R. L., Jensen, R. T. & Brownstein, M. J. (1981) Brain Res. 212, 51-57.
18. Tirassa, P., Stenfors, C., Lundeberg, T. & Aloe, L. (1998) Br. J. Pharmacol. 123, 1230-1236.
19. Franklin, K. B. & Paxinos, G. (1996) The Mouse Brain in Steretoxic Coordinates (Academic, San Diego), 1st Ed.
20. Weskamp, G. & Otten, U. (1987) J. Neurochem. 48, 1776-1786.
21. Fonnum, F. A. (1975) J. Neurochem. 24, 407-409.
22. Linden, A., Uvnas-Moberg, K., Forsberg, G., Bednar, I. & Sodersten, P. (1989) J. Neuroendocrinol. 121, 59-65.
23. Korshing, S., Auurger, G., Heumann, R., Scott, J. & Thoenen, H. (1985) EMBO J. 4, 1389-1393.
24. Friden, P. M., Walus, L. R., Watson, P., Doctrow, S. R., Kozarich, J. W., Backman, C., Bergman, H., Hoffer, B., Bloom, F. & Granholm, A. C. (1993) Science 259, 373-377.
25. Steiner, P., Pfeilschifter, J., Boeckh, C., Radeke, H. & Otten, U. (1991) Am. J. Physiol. 261, F792-F798.
26. Saporito, M. S., Wilcox, H. M., Hartpence, K. C., Lewis, M. E., Vaught, J. L. & Carswell, S. (1993) Exp. Neurol. 123, 295-302.
27. Tirassa, P., Thiblin, I., Agren, G., Vigneti, E., Aloe, L. & Stenfors, C. (1997) J. Neurosci. Res. 47, 198-207.
28. Aloe, L. (1989) Proc. Natl. Acad. Sci. USA 86, 5636-5640.
29. Woodruff, G. N. & Hughes, J. (1991) Annu. Rev. Pharmacol. Toxicol. 31, 469-501.
30. Crawley, J. N. & Beinfeld, M. C. (1983) Nature (London) 302, 703-706.
31. Lieverse, R. J., Jansen, J. B., van de Zwan, A., Samson, A. L., Masclee, A. A. & Lamers, C. B. (1993) Regul. Pept. 43, 83-89.
32. Magnani, M., Mantovani, P. & Pepeu, G. (1984) Neuropharmachology 23, 1305-1309.
33. Sugaya, K., Takahashi, M. & Kubota, K. (1992) Jpn. J. Pharmacol. 59, 125-128.
34. Takahashi, M., Sugaya, K., Kojima, K., Katoh, T., Ueki, M. & Kubota, K. (1993) Jpn. J. Pharmacol. 61, 341-349.
35. Day, H., Mcknight, A. T., Poat, J. A. & Hughes, J. (1994) Neuropharmacol. 33, 719-727.
36. Quirin-Stricker, C., Mauvais, C. & Schmitt, M. (1997) Mol. Brain Res. 49, 165-174.
37. Rossor, M. N., Rehfeld, J. F., Emson, P. C., Mountjoy, C. Q., Roth, M. & Iversen, L. L. (1981) Life Sci. 29, 405-410.
38. Itoh, S. & Lal, H. (1990) Drug Dev. Res. 21, 257-276.
39. Kovacs, G. L. & de Wied, D. (1994) Pharmacol. Rev. 46, 269-291.